- FTC Seeks to Block Virtual Reality Giant Meta’s Acquisition of Popular App Creator Within ( )
- FTC Approves Final Order Preserving Competition for Development and Marketing of Steroid Injectable Drug ( )
- FTC Marks One-Year Anniversary of Government-Wide initiative to Promote Competition in the American Economy ( )
- FTC Approves Final Order Requiring Prince International Corp. and Ferro Corp. to Sell Off Three Facilities amid Concerns that Deal would Increase Concentration in North American Market for Porcelain Enamel Frit ( )
- FTC Approves Final Order Protecting Patients Who Rely on Medical Instruments Used in Sinus Procedures ( )
- FTC Takes Second Action Against JAB Consumer Partners to Protect Pet Owners from Private Equity Firm’s Rollup of Veterinary Services Clinics ( )
- FTC to Ramp Up Enforcement Against Any Illegal Rebate Schemes, Bribes to Prescription Drug Middleman That Block Cheaper Drugs ( )
- Statement of Bureau of Competition Director Holly Vedova Regarding the Decision of Utah Healthcare Competitors HCA Healthcare and Steward Health Care System to Abandon Their Proposed Merger ( )
- FTC Acts to Restore Competitive Markets for Gasoline and Diesel in Michigan and Ohio ( )
- FTC Chair and Commissioners to Host Public Forum Examining the Impacts of Mergers and Acquisitions on June 21 ( )
- FTC and Justice Department to Hold Two-Day Virtual Public Workshop Starting Tomorrow that Re-examines Antitrust Enforcement in the Pharmaceutical Industry ( )
- FTC Acts to Protect Pet Owners from Private Equity Firm’s Anticompetitive Acquisition of Veterinary Services Clinics ( )
- FTC Sues to Block Merger Between New Jersey Healthcare Rivals RWJBarnabas Health and Saint Peter’s Healthcare System ( )
- FTC Acts to Protect South Carolina and Alabama Markets from Anticompetitive Gasoline Terminal Deal ( )
- FTC Sues to Block Merger Between Utah Healthcare Rivals HCA Healthcare and Steward Health Care System ( )
- FTC and Justice Department to Hold Two-Day Virtual Public Workshop Examining Antitrust Enforcement in the Pharmaceutical Industry ( )
- FTC Acts to Protect Patients Who Rely on Medical Instruments Used in Sinus Procedures ( )
- FTC Requires Prince and Ferro to Sell Off Three Facilities amid Concerns that Deal would Increase Concentration in North American Market for Porcelain Enamel Frit ( )
- Federal Trade Commission Preserves Competition for Development and Marketing of Steroid Injectable Drug ( )
- FTC Requires ENCAP to Sell Off EP Energy Corp.'s Entire Utah Oil Business amid Concerns that Deal would Increase Pain at the Pump ( )
- Statement of Federal Trade Commission Bureau of Competition Deputy Director John M. Newman on Federal Appeals Court Ruling Affirming Preliminary Injunction to Halt Merger of New Jersey Hospital Networks ( )
- FTC and DOJ Extend Deadline for Public Comment on Ways to Strengthen Enforcement Against Illegal Mergers ( )
- Federal Trade Commission and Justice Department to Hold Joint Spring Enforcers Summit ( )
- FTC Approves Final Order Imposing Divestitures and Protecting Retail Fuel Customers following Global Partners LP’s Acquisition of Wheels ( )
- Statement Regarding Termination of Attempted Merger of Rhode Island’s Two Largest Healthcare Providers ( )
- Administrative Law Judge Dismisses FTC Antitrust Complaint against Altria Group and JUUL Labs, Inc. ( )
- FTC Approves Modifications to Boston Scientific Corp. Divestiture Agreement ( )
- FTC and Rhode Island Attorney General Step in to Block Merger of Rhode Island’s Two Largest Healthcare Providers ( )
- Statement Regarding Termination of Lockheed Martin Corporation’s Attempted Acquisition of Aerojet Rocketdyne Holdings Inc. ( )
- Statement Regarding Termination of Nvidia Corp.’s Attempted Acquisition of Arm Ltd. ( )